Protein Perforin Found to Trigger Cancer Cell Death

University of Michigan researchers discover that perforin induces iron-dependent cell death in tumor cells.

Updated on Oct. 30, 2026 in Cancer

Macro photograph of complex protein structures interacting with a biological cell membrane in a sterile laboratory environment. — University of Michigan researchers discovered that the protein perforin kills tumor cells by inducing iron-dependent cell death, a process known as ferroptosis. AI Illustration. Upload story photo >

Live Poll

Does new research into cancer cell death pathways give you more hope for future medical treatments?

Researchers have identified that the protein perforin kills cancer cells by triggering ferroptosis, an iron-dependent pathway. The discovery reveals that this mechanism operates independently of the digestive enzymes known as granzymes.

Why it matters

Understanding this alternative cell death pathway provides new insight into how immune cells effectively destroy tumor cells. This discovery could expand the scientific understanding of immune system function in oncology.

The study confirmed that perforin functions independently to trigger an iron-dependent cell death pathway known as ferroptosis. This process involves mitochondrial lipid peroxidation and membrane disruption within tumor cells.

The players

Weiping Zou

He is a researcher at the University of Michigan who co-led the study on perforin and cancer cell death.

Ilona Kryczek

She is a lead researcher involved in the University of Michigan team that identified the ferroptosis mechanism.

Judy Lieberman

She is a scientist at Harvard who collaborated as a lead researcher on the study regarding perforin function.

University of Michigan Health Rogel Cancer Centre

This institution served as the primary research site for the investigation into protein-based cancer cell destruction.

The details

Produced by T cells and natural killer cells, perforin initiates a lethal cascade that destroys tumors without requiring granzymes. Researchers at the University of Michigan and Harvard mapped this pathway by observing direct membrane and mitochondrial impacts.

October 30, 2026: Findings were officially published.

The Big Picture

This discovery marks a departure from the traditional granzyme-mediated cell death paradigm. By identifying a parallel, iron-dependent pathway, the research shifts the theoretical understanding of how immune cells target and dismantle tumors.

This research provides fundamental insights into immune-mediated tumor destruction that could eventually influence new cancer treatment strategies. It does not currently change existing medical routines or healthcare access for patients.

The takeaway

This study highlights that the immune system possesses redundant and complex pathways for eliminating threats. Future research will likely explore how these specific mechanisms can be harnessed to enhance cancer immunotherapies.